Skip to main content
Full access
Windows to the Brain
Published Date: 1 January 2025

Myokines and the Brain: A Novel Neuromuscular Endocrine Loop

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
Exercise can improve and strengthen various aspects of brain structure and function, such as volume, connectivity, neurogenesis, neuroplasticity, and cognition (2630). In addition, exercise has numerous benefits for the overall mental health of individuals, including lowering the risk for neurodegenerative diseases. However, the specific neural and peripheral physiologic mechanisms linking exercise to these positive effects in the central nervous system (CNS) remain unclear (26, 30, 31).
Myokines belong to a specific group of exerkines-signaling moieties. They correspond to a subset of muscle-derived bioactive molecules (e.g., cytokines, small peptides, polypeptides, growth factors, and organic acids) that perform important functions, mediating cognition and other brain functions in response to exercise (1, 7, 10). Myokines are synthesized and secreted by myocytes in response to skeletal muscle activation and contractions primarily induced by exercise, specifically high-intensity resistance training (Figure 1A) (25).
FIGURE 1. A: Exercise (cyan) commonly refers to a form of physical activity that is more intentional (e.g., promotion of physical change, body contouring, and overall health), such as cardiovascular exercise (e.g., aerobics, cycling, and running) and resistance training (e.g., weightlifting, bodyweight calisthenics, and high-intensity interval training [HIIT] exercises [white]) (1). Myokines are synthesized and secreted by myocytes (muscle cells) in response to skeletal muscle activation primarily induced by high-intensity resistance training (brief repeated bursts of vigorous exercise interspersed with periods of rest or low-intensity exercise for recovery) (15). B: Myokines’ chemical signaling. Once released, myokines are activated in an autocrine, paracrine, or endocrine fashion (6). C: Muscle-brain axis (MBA). Some myokines can cross the blood-brain barrier, facilitating signaling pathways and potentiating many exercise-induced brain benefits (69). In the central nervous system, they constitute an intertissue cross-talk between skeletal muscle and the brain (7, 912).
After their (transient or continuous) secretion, myokines are physiologically active in an autocrine, paracrine, or endocrine fashion in other tissues and organs of the body (e.g., bones, adipose tissue, liver, and brain) (6). However, most myokines can have paracrine functions, and some can cross the blood-brain barrier, facilitating signaling pathways and potentiating exercise-induced brain benefits (69). Myokines also exert important functions as communication conduits between muscles and many other tissues (32). In the CNS, they constitute an important biomolecular substrate for cross-talk between skeletal muscle and the brain via an integrative endocrine loop, the muscle-brain axis (MBA) (Figure 1B–C) (7, 912).
Hundreds of myokines have been described in the literature. Some of those most relevant to the brain include brain-derived neurotrophic factor (BDNF), insulin-like growth factor–1 (IGF-1), cathepsin B (CTSB), fibronectin type III domain–containing protein 5 (FNDC5)/irisin, l-lactate, and vascular endothelial growth factor (VEGF) (3, 7, 8).
Myokines have broad bioactivity and physiologic versatility (i.e., autocrine, endocrine, and paracrine capabilities) in restoring metabolic balance and health (7). This realization has led to a greater understanding of the relevance of muscle tissue and exercise for human health (3). However, despite their general health benefits, not all myokines can potentiate brain effects. Only a few can exert neurologic functions and signal neurophysiologic processes (6, 7, 10, 12). However, the specific functions of myokines remain poorly understood (7).

Myokines and Their Effects in the Brain

It seems that a continuous cross-talk takes place between the muscular and nervous systems. The brain is the ultimate sensor for exercise and other activities (3, 9). Many exercise-induced myokines (e.g., BDNF, IGF-1, and CTSB) can improve brain tissue and cognitive function, including memory (6, 13, 29). Skeletal muscle myokines induced by exercise can act on brain structures, such as the hippocampus, improving neurogenesis, mood, memory, and learning (Figure 2A) (9, 13). Furthermore, some myokines (e.g., BDNF) may slow progression of chronic diseases among older people (e.g., sarcopenia, Alzheimer’s dementia, and depression), preventing cognitive decline and improving neurogenesis, mood, and motor function (22).
FIGURE 2. A: The effect of myokines in the brain. Important brain myokines include brain-derived neurotrophic factor (BDNF), insulin-like growth factor–1 (IGF-1), cathepsin B (CTSB), fibronectin type III domain–containing protein 5 (FNDC5)/irisin, l-lactate, and vascular endothelial growth factor (VEGF) (3, 7, 8). These myokines act on certain brain structures and improve many neural functions (7, 9, 13). B: Myokine synergism. Myokines appear to exhibit functional synergisms, further potentiating multiple neural functions. Together, IGF-1, CTSB, FNDC5/irisin, and l-lactate upregulate the expression of BDNF, which increases brain signaling and conveys other neurologic benefits (e.g., prevention of cognitive decline and improving neurogenesis) (6, 1422). l-Lactate increases cognitive abilities (i.e., learning and memory) and neural signaling and seems to exert antidepressant effects (1719, 23, 24). In addition, it appears to increase the expression of VEGF in the brain. In turn, VEGF is linked to neuroprotection, neurogenesis, and increased signaling properties (20, 21, 25).
COVER. Artistic depiction of the muscle-brain axis endocrine loop (simplified). The multicolor spheres represent the variety of myokines secreted from skeletal muscle cells. The spectral coloring represents a repertoire of neural benefits and functions that these neuroactive molecules exert in the brain. BDNF=brain-derived neurotrophic factor; CTSB=cathepsin B; FNDC5=fibronectin type III domain–containing protein 5/irisin; IGF-1=insulin-like growth factor–1; VEGF=vascular endothelial growth factor.
All images and figures were created with Canva, BioRender.com and VH Dissector, for which the Mid-Atlantic (VISN 6) MIRECC holds renewable registrations.

BDNF

BDNF is present at high concentrations in the human CNS. Approximately 70%–80% of circulating BDNF, at rest and during exercise, originates from the brain, potentially mediating (in part) its positive effects on cognition (13, 33, 34). BDNF appears to work in conjunction with other important myokines, such as CTSB, IGF-1, and FNDC5, which in turn amplifies its bioavailability and brain-signaling capabilities. These myokines seem to act synergistically as MBA molecular substrates of exercise-induced neuroplasticity (Figure 2B) (6, 9). Exercise-induced BDNF in skeletal muscle can cross the blood-brain barrier, further supporting the potential benefits of BDNF on cognition and mood. These effects appear to depend on the type of exercise and its duration, because levels of BDNF increase with acute and intense exercise sessions (9). Preliminary results suggest that BDNF might be a promising predictor of intervention responses among individuals with major depressive disorder (35).

IGF-1

IGF-1 acts as an upstream regulator of BDNF and helps to regulate gene expression involved in BDNF-related neurogenesis (14). Both myokines are important CNS regulators, promoting the development and maintenance of neural circuits and other pathways (6, 36). IGF-1 is synthesized in various structures, such as the cortex, cerebellum, hippocampus, and hypothalamus (37). When produced peripherally (in the liver and muscles), this molecule can access the brain by crossing the blood-brain barrier and the choroid plexuses (37, 38).
IGF-1 has a wide range of functions in the brain, such as neurogenesis, neuroprotection, neuroplasticity, regeneration, synaptogenesis, and antiapoptotic signaling, among others (37). Exercise-induced IGF-1 levels rapidly rise in humans in response to acute sessions of high-intensity physical activity (38, 39). Recent reviews and reports from studies in rodents have indicated that IGF-1 has antidepressant effects (Figure 2A–B) (4042). However, the role of IGF-1 as an antidepressant in clinical studies requires further investigation (35).

CTSB

CTSB is a member of the lysosomal cysteine protease family and is synthesized, upregulated, and secreted from muscle cells; therefore, it is considered a myokine (6). Exercise-induced CTSB has been associated with improved brain function (6). In mice, increased CTSB has been linked to spatial object recognition (a function of hippocampal-dependent memory) after long-term running sessions, suggesting that CTSB mediates the effects of exercise on cognition (29). Another study in mice reported that skeletal muscle–derived CTSB improves cognitive function by upregulating BDNF and doublecortin in the hippocampus, which further mediates neuroplasticity, neuronal survival, and migration (Figure 2A) (15).
In a study of 40 healthy middle-aged people (43), higher concentrations of circulating CTSB were associated with increased cognitive control and faster information processing speed. These findings appear to link CTSB to both cognitive control and neuroelectric function in the brain. However, the medical evidence on benefits of exercise-induced CTSB is still scarce. More clinical investigations are essential to better understand its multifactorial roles, especially in the CNS (6).

FNDC5/Irisin

Irisin is another myokine whose synthesis (by proteolytic cleavage from its precursor FNDC5) and secretion are induced by exercise. In humans, about 70% of irisin is produced in skeletal muscle cells, with the remainder generated in other tissues, such as the brain and white adipose tissue (6, 31). High-intensity exercise increases irisin secretion (44). In one study (45), adolescent males had higher circulating irisin concentrations than their female counterparts after aerobic exercise and at rest. However, it is not clear whether these sex differences persist throughout adulthood (44, 45). Once released from muscles, irisin can access the brain by crossing the blood-brain barrier (46). It appears to have an important role in mitochondrial function, inflammatory responses, metabolic diseases, and aging (6). In addition, irisin seems to be involved in CNS regulatory processes, such as neurogenesis, neuroprotection, neurotrophic factor imbalance, insulin resistance, and oxidative stress (Figure 2A) (44, 47). In the brain, exercise appears to be a powerful potentiator of hippocampal FNDC5 (along with BDNF) via the peroxisome proliferator–activated receptor gamma coactivator 1-alpha and the estrogen-related receptor alpha (PGC-1α-Errα) transcriptional signaling pathways. Therefore, exercise-induced FNDC5 expression upregulates hippocampal levels of BDNF (Figure 2B) (16).
Recent findings from rodent studies suggest that exercise-inducible irisin is an important regulator of cognitive processes, which may have translational potential (44, 48, 49). FNDC5/irisin gene deletion affects cognitive function among patients with Alzheimer’s disease (49); another study linked irisin to episodic memory and global cognition among individuals at risk for dementia (50). A clinical trial reported positive correlations between serum levels of irisin and amyloid beta, as well as improved metabolic and neurocognitive indices among overweight individuals with genetic risks for Alzheimer’s disease (51).
In addition, findings from a study in rats suggest that irisin may offer therapies for alleviating depression (52). Other studies have indicated that exercise-induced irisin acts on the hippocampal PGC-1α–FNDC5/irisin pathway, reducing symptoms of depression (5355). Overall, exercise-induced irisin (peripherally and in the CNS) is relevant in certain neurologic disorders, but its potential clinical implications remain unclear (6, 44).

l-Lactate

l-Lactate production is triggered by intense exercise conditions and ischemia. Among adults, about half of the daily production of l-lactate occurs within the muscles and skin, with the remainder produced in red blood cells (20%), brain (20%), and intestines (10%) (56). Once released, l-lactate penetrates the blood-brain barrier via monocarboxylic acid transporters to enter the brain. These transporters also facilitate its access to other tissues and organs (5, 57). Typically, l-lactate transfers from its sites of production to other locations depending on physiologic demand (e.g., from glia to neurons, between different myofibers in skeletal muscle, and from skeletal muscles to the brain) via peripheral blood circulation (57).
l-Lactate has been described by some researchers as the preferred form of energy for metabolic processes in the brain (58). Glucose enters astrocytes and oligodendrocytes and produces l-lactate via glycolysis. l-Lactate is then produced by glycogenolysis and glycolysis. Exogenous l-lactate enters neurons via monocarboxylate transporter 2, where it serves as a metabolite and is converted to pyruvate, thus producing energy within the neuronal mitochondria (18).
Monocarboxylic acid transporter–mediated transport of l-lactate inside hippocampal neurons intensifies BDNF expression via induction of PGC-1α and silent information regulator 1 transcriptional signaling pathways. Increased BDNF expression in turn induces FNDC5 signaling, a process that improves spatial learning and memory in mice (Figure 2B) (17). A novel l-lactate receptor, hydroxycarboxylic acid receptor 1, was recently discovered in the brain, providing an additional mechanism by which l-lactate can enter nerve cells and regulate neural function (e.g., similar to neurotransmitters) (18). Furthermore, hydroxycarboxylic acid receptor 1 is linked to neuronal firing activity, possibly facilitating memory and learning processes (19, 59).
l-Lactate has also been linked to multifunctional signaling capabilities with theoretical potential for clinical and psychiatric interventions (18, 58, 60). Peripheral l-lactate administration was associated with antidepressant effects in rodent models (23, 24, 61). Furthermore, a recent review of clinical studies (18) found increased brain l-lactate levels among patients with depression compared with those of healthy control subjects. Therefore, exogenous l-lactate administration might lead to positive clinical outcomes, including improved mental health status (18).

VEGF

VEGF is also produced by myofibers during exercise and can cross the blood-brain barrier (25). VEGF has been linked to angiogenesis and the maintenance of normal blood circulation in the hippocampus (i.e., cerebrovascular blood flow) in response to acute exercise. An important positive effect of VEGF is promoting hippocampal neurogenesis, activating the proliferation of neural stem cells in the dentate gyrus (62). A study in mice (20) reported increased levels of exercise-induced VEGF in the hippocampus, seemingly connected to the benefits of exercise on learning and memory.
VEGF expression in the brain appears to be increased by l-lactate. This observation provides further evidence that VEGF and other myokines (e.g., BDNF and irisin) act together as muscle-to-brain cross-talk molecules that potentiate neuroprotection, neurogenesis, increased signaling, and other benefits of the MBA (21). Furthermore, VEGF is responsible, in part, for the higher numbers of neuronal precursor cells and larger hippocampal volume that result from exercise (Figure 2A–B) (25).

Conclusions

Exercise generates important neurophysiologic effects in the brain. Myokines are exercise-induced neuroactive substances similar to neurotransmitters and have a key role in the muscle-brain endocrine loop. They seem to sustain (at least in part) some of the physiologic mechanisms underlying the positive effects of exercise in the nervous system.
Myokines, such as BDNF, IGF-1, CTSB, FNDC5/irisin, and l-lactate, appear to exhibit synergistic physiologic mechanisms, allowing them to amplify each other’s signals and functions via reciprocal biochemical pathways. Understanding the specific molecular mechanisms of myokines is essential for the development of new pharmacologic therapies and complementary exercise-based interventions, particularly for older individuals, those with physical impairments, and individuals with brain disorders.
In addition, the direct and indirect effects of myokines on the peripheral and autonomic nervous system among healthy individuals remain unclear and require more in-depth investigations. Although these neuroactive substances hold physiologic potential, a significant gap in the scientific evidence remains regarding possible benefits for patients with neurologic, psychiatric, or neurodegenerative diseases.

References

1.
Chow LS, Gerszten RE, Taylor JM, et al: Exerkines in health, resilience and disease. Nat Rev Endocrinol 2022; 18:273–289
2.
Gomarasca M, Banfi G, Lombardi G: Myokines: the endocrine coupling of skeletal muscle and bone. Adv Clin Chem 2020; 94:155–218
3.
Zunner BEM, Wachsmuth NB, Eckstein ML, et al: Myokines and resistance training: a narrative review. Int J Mol Sci 2022; 23:3501
4.
Giannaki CD, Sakkas GK, Hadjigeorgiou GM, et al: Unfolding the role of exercise in the management of sleep disorders. Eur J Appl Physiol 2024; 124:2547–2560
5.
Huang Z, Zhang Y, Zhou R, et al: Lactate as potential mediators for exercise-induced positive effects on neuroplasticity and cerebrovascular plasticity. Front Physiol 2021; 12:656455
6.
Kim S, Choi JY, Moon S, et al: Roles of myokines in exercise-induced improvement of neuropsychiatric function. Pflugers Arch 2019; 471:491–505
7.
Vints WAJ, Gökçe E, Langeard A, et al: Myokines as mediators of exercise-induced cognitive changes in older adults: protocol for a comprehensive living systematic review and meta-analysis. Front Aging Neurosci 2023; 15:1213057
8.
Vints WAJ, Levin O, Fujiyama H, et al: Exerkines and long-term synaptic potentiation: mechanisms of exercise-induced neuroplasticity. Front Neuroendocrinol 2022; 66:100993
9.
Pedersen BK: Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol 2019; 15:383–392
10.
Oudbier SJ, Goh J, Looijaard SMLM, et al: Pathophysiological mechanisms explaining the association between low skeletal muscle mass and cognitive function. J Gerontol A Biol Sci Med Sci 2022; 77:1959–1968
11.
Chen W, Wang L, You W, et al: Myokines mediate the cross talk between skeletal muscle and other organs. J Cell Physiol 2021; 236:2393–2412
12.
Burtscher J, Millet GP, Place N, et al: The muscle-brain axis and neurodegenerative diseases: the key role of mitochondria in exercise-induced neuroprotection. Int J Mol Sci 2021; 22:6479
13.
Szuhany KL, Bugatti M, Otto MW: A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res 2015; 60:56–64
14.
Jeon YK, Ha CH: Expression of brain-derived neurotrophic factor, IGF-1 and cortisol elicited by regular aerobic exercise in adolescents. J Phys Ther Sci 2015; 27:737–741
15.
Kobilo T, Yuan C, van Praag H: Endurance factors improve hippocampal neurogenesis and spatial memory in mice. Learn Mem 2011; 18:103–107
16.
Wrann CD, White JP, Salogiannnis J, et al: Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 2013; 18:649–659
17.
El Hayek L, Khalifeh M, Zibara V, et al: Lactate mediates the effects of exercise on learning and memory through SIRT1-dependent activation of hippocampal brain-derived neurotrophic factor (BDNF). J Neurosci 2019; 39:2369–2382
18.
Cai Y, Guo H, Han T, et al: Lactate: a prospective target for therapeutic intervention in psychiatric disease. Neural Regen Res 2024; 19:1473–1479
19.
de Castro Abrantes H, Briquet M, Schmuziger C, et al: The lactate receptor HCAR1 modulates neuronal network activity through the activation of Gα and Gβγ subunits. J Neurosci 2019; 39:4422–4433
20.
Karakilic A, Yuksel O, Kizildag S, et al: Regular aerobic exercise increased VEGF levels in both soleus and gastrocnemius muscles correlated with hippocampal learning and VEGF levels. Acta Neurobiol Exp 2021; 81:1–9
21.
Rai M, Demontis F: Muscle-to-brain signaling via myokines and myometabolites. Brain Plast 2022; 8:43–63
22.
Wang B, Liang J, Lu C, et al: Exercise regulates myokines in aging-related diseases through muscle-brain crosstalk. Gerontology 2024; 70:193–209
23.
Carrard A, Cassé F, Carron C, et al: Role of adult hippocampal neurogenesis in the antidepressant actions of lactate. Mol Psychiatry 2021; 26:6723–6735
24.
Karnib N, El-Ghandour R, El Hayek L, et al: Lactate is an antidepressant that mediates resilience to stress by modulating the hippocampal levels and activity of histone deacetylases. Neuropsychopharmacology 2019; 44:1152–1162
25.
Ballard HJ: Exercise makes your brain bigger: skeletal muscle VEGF and hippocampal neurogenesis. J Physiol 2017; 595:5721–5722
26.
Cabral DF, Rice J, Morris TP, et al: Exercise for brain health: an investigation into the underlying mechanisms guided by dose. Neurotherapeutics 2019; 16:580–599
27.
Bangsbo J, Blackwell J, Boraxbekk CJ, et al: Copenhagen Consensus statement 2019: physical activity and ageing. Br J Sports Med 2019; 53:856–858
28.
Lee B, Shin M, Park Y, et al: Physical exercise–induced myokines in neurodegenerative diseases. Int J Mol Sci 2021; 22:5795
29.
Moon HY, Becke A, Berron D, et al: Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metab 2016; 24:332–340
30.
Duzel E, van Praag H, Sendtner M: Can physical exercise in old age improve memory and hippocampal function? Brain 2016; 139:662–673
31.
Jodeiri Farshbaf M, Alviña K: Multiple roles in neuroprotection for the exercise derived myokine irisin. Front Aging Neurosci 2021; 13:649929
32.
Pedersen L, Hojman P: Muscle-to-organ cross talk mediated by myokines. Adipocyte 2012; 1:164–167
33.
Heyman E, Gamelin FX, Goekint M, et al: Intense exercise increases circulating endocannabinoid and BDNF levels in humans—possible implications for reward and depression. Psychoneuroendocrinology 2012; 37:844–851
34.
Rasmussen P, Brassard P, Adser H, et al: Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009; 94:1062–1069
35.
Mosiołek A, Mosiołek J, Jakima S, et al: Effects of antidepressant treatment on neurotrophic factors (BDNF and IGF-1) in patients with major depressive disorder (MDD). J Clin Med 2021; 10:3377
36.
Robinson-Agramonte MLA, Michalski B, Vidal-Martinez B, et al: BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism. Sci Rep 2022; 12:13768
37.
Dyer AH, Vahdatpour C, Sanfeliu A, et al: The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 2016; 325:89–99
38.
Stein AM, Silva TMV, Coelho FGM, et al: Physical exercise, IGF-1 and cognition A systematic review of experimental studies in the elderly. Dement Neuropsychol 2018; 12:114–122
39.
Schwarz AJ, Brasel JA, Hintz RL, et al: Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996; 81:3492–3497
40.
Deyama S, Kondo M, Shimada S, et al: IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine. Transl Psychiatry 2022; 12:178
41.
Yang C, Sui G, Li D, et al: Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice. Physiol Behav 2021; 229:113236
42.
Burgdorf J, Zhang XL, Colechio EM, et al: Insulin-like growth factor I produces an antidepressant-like effect and elicits N-methyl-d-aspartate receptor independent long-term potentiation of synaptic transmission in medial prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 2015; 19:pyv101
43.
Kim J, McKenna CF, Salvador AF, et al: Cathepsin B and muscular strength are independently associated with cognitive control. Brain Plast 2022; 8:19–33
44.
Zhang Y, Zhang X, Lin S: Irisin: a bridge between exercise and neurological diseases. Heliyon 2022; 8:e12352
45.
Kabasakalis A, Nikolaidis S, Tsalis G, et al: Effects of sprint interval exercise dose and sex on circulating irisin and redox status markers in adolescent swimmers. J Sports Sci 2019; 37:827–832
46.
Phillips C, Baktir MA, Srivatsan M, et al: Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci 2014; 8:170
47.
Mahgoub MO, D’Souza C, Al Darmaki RSMH, et al: An update on the role of irisin in the regulation of endocrine and metabolic functions. Peptides 2018; 104:15–23
48.
Park J, Kim J, Mikami T: Exercise hormone irisin prevents physical inactivity–induced cognitive decline in mice. Behav Brain Res 2022; 433:114008
49.
Islam MR, Valaris S, Young MF, et al: Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab 2021; 3:1058–1070
50.
Küster OC, Laptinskaya D, Fissler P, et al: Novel blood-based biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of dementia: preliminary evidence for a role of BDNF, irisin, and the kynurenine pathway. J Alzheimers Dis 2017; 59:1097–1111
51.
Tsai CL, Pai MC: Circulating levels of irisin in obese individuals at genetic risk for Alzheimer’s disease: correlations with amyloid-β, metabolic, and neurocognitive indices. Behav Brain Res 2021; 400:113013
52.
Wang S, Pan J: Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism. Biochem Biophys Res Commun 2016; 474:22–28
53.
Schuch FB, Vancampfort D, Richards J, et al: Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res 2016; 77:42–51
54.
Wrann CD: FNDC5/irisin—their role in the nervous system and as a mediator for beneficial effects of exercise on the brain. Brain Plast 2015; 1:55–61
55.
Jo D, Song J: Irisin acts via the PGC-1α and BDNF pathway to improve depression-like behavior. Clin Nutr Res 2021; 10:292–302
56.
Gladden LB: Lactate metabolism: a new paradigm for the third millennium. J Physiol 2004; 558:5–30
57.
Bergersen LH: Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction. J Cereb Blood Flow Metab 2015; 35:176–185
58.
Smith D, Pernet A, Hallett WA, et al: Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab 2003; 23:658–664
59.
Briquet M, Rocher AB, Alessandri M, et al: Activation of lactate receptor HCAR1 down-modulates neuronal activity in rodent and human brain tissue. J Cereb Blood Flow Metab 2022; 42:1650–1665
60.
Lee TY: Lactate: a multifunctional signaling molecule. Yeungnam Univ J Med 2021; 38:183–193
61.
Carrard A, Elsayed M, Margineanu M, et al: Peripheral administration of lactate produces antidepressant-like effects. Mol Psychiatry 2018; 23:488
62.
Rich B, Scadeng M, Yamaguchi M, et al: Skeletal myofiber vascular endothelial growth factor is required for the exercise training–induced increase in dentate gyrus neuronal precursor cells. J Physiol 2017; 595:5931–5943

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: A4 - 4
PubMed: 39812655

History

Received: 28 August 2024
Accepted: 25 October 2024
Published online: 1 January 2025
Published in print: Winter 2025

Keywords

  1. Muscle-Brain Axis
  2. Myokines
  3. Neuroanatomy
  4. Neuroendocrinology
  5. Neuromuscular
  6. Exercise

Authors

Details

Wilfredo López-Ojeda, Ph.D., M.S.
Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center and the Research and Academic Affairs Service Line, W. G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (López-Ojeda, Hurley); Department of Psychiatry and Behavioral Medicine (López-Ojeda, Hurley) and Department of Radiology (Hurley), Wake Forest University School of Medicine, Winston-Salem, N.C.
Robin A. Hurley, M.D., F.A.N.P.A. robin.hurley@va.gov
Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center and the Research and Academic Affairs Service Line, W. G. Hefner Veterans Affairs Medical Center, Salisbury, N.C. (López-Ojeda, Hurley); Department of Psychiatry and Behavioral Medicine (López-Ojeda, Hurley) and Department of Radiology (Hurley), Wake Forest University School of Medicine, Winston-Salem, N.C.

Notes

Send correspondence to Dr. Hurley (robin.hurley@va.gov).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

Supported by the U.S. Department of Veterans Affairs Veterans Integrated Services Network 6 Mental Illness Research Education and Clinical Center.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figures

Tables

Media

Share

Share

Share article link

Share